DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status.
Jurmeister P, Weber K, Villegas S, Karn T, Untch M, Thieme A, Müller V, Taube E, Fasching P, Schmitt WD, Marmé F, Stickeler E, Sinn BV, Jank P, Schem C, Klauschen F, van Mackelenbergh M, Denkert C, Loibl S, Capper D.
Jurmeister P, et al. Among authors: villegas s.
Clin Epigenetics. 2021 Oct 3;13(1):184. doi: 10.1186/s13148-021-01176-5.
Clin Epigenetics. 2021.
PMID: 34602069
Free PMC article.